Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Adults Aged 40+
NCT06851832Phase 2Active, not recruiting
- Sponsor
- Ab&B Bio-tech Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Oct 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by Ab&B Bio-tech Co., Ltd.. Started Feb 2025; status: active, not recruiting.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT06851832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06851832.